Zhuhai Trinomab Pharmaceutical (SHA:688806) is seeking to raise 998.9 million yuan via the issue of 69.1 million shares at 14.46 yuan apiece, according to a Thursday filing with the Shanghai bourse.
The expected offering date is July 10, with proceeds to be used for new drug research and development, antibody manufacturing expansion, and for working capital.
Huatai United Securities serves as lead underwriter.